Size	Price	VIP Price	US Stock	Global Stock	In Stock
{[ item.pr_size ]}		Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

CAS No. :	915942-22-2
Formula :	C₃₄H₃₃ClN₆O₇
M.W :	673.11
SMILES Code :	O=C(NC1=C(OCC)C=C2N=CC(C#N)=C(NC3=CC=C(OCC4=NC=CC=C4)C(Cl)=C3)C2=C1)/C=C/CN(C)C.O=C(O)/C=C\C(O)=O
Synonyms :	HKI-272 maleate
MDL No. :	MFCD30607264
InChI Key :	VXZCUHNJXSIJIM-MEBGWEOYSA-N
Pubchem ID :	67307512

GHS Pictogram:
Signal Word:	Warning
Hazard Statements:	H302-H315-H319-H335
Precautionary Statements:	P261-P305+P351+P338

SKBR3	5 nM	1 h	To evaluate the effect of Neratinib on SKBR3 cells, results showed that Neratinib significantly inhibited HER2 signaling in SKBR3 cells.	PMC6693253
PANC1 cells	100 nM	12 hours	To evaluate the cytotoxic effect of Neratinib on PANC1 cells, results showed that Neratinib caused ~15–20% cell killing.	PMC7133220
TBCP-1	300 nM	24 h	To evaluate the effect of Neratinib on TBCP-1 cells, results showed that Neratinib significantly inhibited TBCP-1 cell proliferation and induced ferroptosis.	PMC6693253
MDA-MB-453	10 nM	24 hours	Neratinib monotherapy significantly inhibited cell viability compared to control or trastuzumab, and its combination with trastuzumab was also the most potent combination.	PMC11182766
MDA-MB-361	10 nM	24 hours	Neratinib monotherapy significantly inhibited cell viability compared to control or trastuzumab, and its combination with trastuzumab was also the most potent combination.	PMC11182766
BT-474	1 μM	24 hours	To evaluate the effect of Neratinib on downstream signaling pathways. Results showed that Neratinib alone reduced phosphorylation levels of ERK1/2, Akt, and S6K.	PMC8075007
SK-BR-3	1 μM	24 hours	To evaluate the effect of Neratinib on downstream signaling pathways. Results showed that Neratinib alone reduced phosphorylation levels of ERK1/2, Akt, and S6K.	PMC8075007
HCC1954	150 nM	24 hours	To evaluate the effect of Neratinib and Dasatinib on intracellular signaling, results showed that Neratinib significantly inhibited EGFR phosphorylation	PMC11396364
HCC1954-N	150 nM	24 hours	To evaluate the effect of Neratinib and Dasatinib on intracellular signaling, results showed that Neratinib significantly inhibited EGFR Y1068 phosphorylation	PMC11396364
HME2-BM cells	100 nM	4 weeks	To evaluate the effect of Neratinib on the drug resistance of HME2-BM cells, results showed that HME2-BM cells were able to spontaneously develop resistance after prolonged Neratinib treatment.	PMC9213622
Jurkat T cells	50 nM	6 hours	To evaluate the effect of Neratinib on the expression of K-RAS, MST3, and MST4 in Jurkat T cells, results showed that Neratinib significantly reduced the expression of these proteins.	PMC7133220
HL60 cells	50 nM	6 hours	To evaluate the effect of Neratinib on the expression of K-RAS, MST3, and MST4 in HL60 cells, results showed that Neratinib significantly reduced the expression of these proteins.	PMC7133220
T cell lymphoma cells	50 nM	6 hours	Neratinib significantly reduced the total expression and phosphorylation of MST4.	PMC10324541
INS-1E cells	5 μM, 10 μM	72 hours	Neratinib potently inhibited H2O2- and high glucose/palmitate-induced MST1 activation and apoptosis in β-cells	PMC6825211
human islet cells	10 μM, 25 μM	72 hours	Neratinib significantly inhibited pro-inflammatory cytokine- and high glucose/palmitate-induced MST1 activation and caspase-3 activation	PMC6825211
HME2 cells	1 µM	96 hours	To evaluate the inhibitory effect of Neratinib on HER2 phosphorylation, results showed that Neratinib significantly inhibited HER2 phosphorylation and led to receptor degradation.	PMC9213622
Pancreatic cancer cells	50 nM		Neratinib exhibited lethality in pancreatic cancer cells, and its lethality was enhanced when combined with HDAC inhibitors.	PMC10324541

Mice	CW2 xenograft model	Oral gavage	40 mg/kg	Once daily for 14 days	To study the effect of combined neratinib and alpelisib on tumor growth in CW2 xenograft models.	PMC8355076
Mice	STZ-induced type 1 diabetes model and obese Leprdb/db diabetes model	intraperitoneal injection	5 mg/kg	daily for 35 days (STZ model) or 31 days (db/db model)	Neratinib significantly attenuated hyperglycemia and restored β-cell function, survival, and β-cell mass	PMC6825211
Mice	HER2-positive breast cancer xenograft models	Oral	20 mg/kg	Once daily, 5 days/week	To evaluate the therapeutic benefit of N+T and compare its efficacy to P+T using HER2+breast cancer xenograft models. The results showed that N+T was more effective than P+T in accelerating tumor regression and achieving complete response.	PMC8159999
Nude mice	Patient-derived xenografts (PDXs)	Oral	10 mg/kg	Daily for the duration of the experiment	To evaluate the effect of Neratinib in combination with other inhibitors on tumor growth in HER2+ PDX models. Results showed that the combination of Neratinib with palbociclib significantly reduced tumor volume and extended event-free survival in all five PDX models.	PMC8075007
Female Albino Wistar rats	Neratinib-induced diarrhea model	Oral	50 mg/kg	Once daily for 28 days	To investigate the impact of antibiotics on neratinib-induced diarrhea. Results showed that vancomycin or neomycin significantly reduced diarrhea levels, while the broad-spectrum antibiotic cocktail was less effective.	PMC9111977
BALB/c Nude mice	HCC1954 xenograft model	Oral	Neratinib 10 mg/kg, Dasatinib 15 mg/kg	5 days on, 2 days off for 10 weeks	To evaluate the anti-tumor effect of Neratinib and Dasatinib in vivo on HCC1954 xenograft model, results showed that the combination significantly inhibited tumor growth	PMC11396364
NSG mice	HER2+ breast cancer model	Oral gavage	27 mg/kg	Every other day, until tumors reached 1000 mm3	To evaluate the therapeutic effect of Neratinib on HER2+ breast cancer model, results showed that Neratinib significantly inhibited the growth of HME2 parental tumors, but had a smaller effect on the growth of HME2-BM tumors, and overexpression of TG2 diminished the effectiveness of Neratinib.	PMC9213622
BALB/C mice	HER2-positive breast cancer brain metastasis model	Oral gavage	60 mg/kg	Once daily for 3 weeks	To evaluate the efficacy of Neratinib in a preventive neoadjuvant setting, results showed that Neratinib significantly prolonged survival and reduced the incidence of brain metastases.	PMC6693253

{[proInfo.proName]}

CAS No.: 915942-22-2

{[proInfo.proName]}

CAS No.: 915942-22-2

Alternative Products

Product Details of Neratinib maleate

Safety of Neratinib maleate

Related Pathways of Neratinib maleate

Isoform Comparison

Biological Activity

Protocol

References

Historical Records

Categories

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry

Molarity Calculator

Total Compounds Calculator

Dissolution Calculator

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed